SARS-CoV-2 reinfection in a cancer patient with a defective neutralizing humoral response

J Med Virol. 2021 Dec;93(12):6444-6446. doi: 10.1002/jmv.27200. Epub 2021 Jul 20.

¹ Virology Unit, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy.
² Viral Pathogenesis Unit, Department of Public Health and Pediatric Sciences, University of Turin, Turin, Italy.
³ CAAD-Center for Translational Research on Autoimmune and Allergic Disease, University of Piemonte Orientale, Novara, Italy.
⁴ Department of Biomedical and Clinical Sciences L. Sacco, University of Milan, Milan, Italy.
⁵ Division of Internal and Emergency Medicine, Department of Translational Medicine, University of Piemonte Orientale and "Maggiore della Carità" Hospital, Novara, Italy.
⁶ Unit of Microbiology and Virology, Department of Laboratory Medicine, "Maggiore della Carità" Hospital, Novara, Italy.
⁷ Division of Oncology, Department of Translational Medicine, University of Piemonte Orientale and "Maggiore della Carità" Hospital, Novara, Italy.

No abstract available

Keywords: SARS-CoV-2; cancer patient; neutralization humoral response; reinfection.

Publication types